Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind，Placebo- and Active-controlled Adaptive Study

NCT01762163 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT01762163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01762163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind，Placebo- and Active-controlled Adaptive Study
Lead sponsor
China Academy of Chinese Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
October 31, 2016
Enrollment
622 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke